AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA
3.2900
13-十一月-24 16:45:00
15 分钟延时
股票
-0.0400
-1.20%
今日范围
3.2600 - 3.5400
ISIN
N/A
来源
NASDAQ
-
15 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics announces Board changes
20 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
09 1月 2023 07:00:02 条件 Nasdaq GlobeNewswire
-
Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs
21 12月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
12 12月 2022 10:00:00 条件 Nasdaq GlobeNewswire
-
Autolus Announces Pricing of Public Offering
08 12月 2022 21:11:25 条件 Nasdaq GlobeNewswire
-
Autolus Announces Proposed Public Offering in the United States
08 12月 2022 16:03:13 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences
08 12月 2022 16:02:48 条件 Nasdaq GlobeNewswire
-
08 12月 2022 16:01:35 条件 Nasdaq GlobeNewswire
-
30 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
03 11月 2022 09:31:08 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational Progress
03 11月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022
21 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Moderna exercises option to license proprietary targeting technology from Autolus
12 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
04 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress
04 8月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Correction - Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
21 7月 2022 07:54:01 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
21 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
06 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress
10 6月 2022 03:01:00 条件 Nasdaq GlobeNewswire